Crescent Biopharma, Inc. · NASDAQ:CBIO
Lynch Ryan sold 240 Crescent Biopharma, Inc. shares (Form 4)
Traded Sep 16, 2026 · Filed Sep 18, 2026
On Sep 16, 2026, Lynch Ryan (See Remarks) sold 240 Crescent Biopharma, Inc. shares at US$17.90 for US$4,296 under a trading plan, leaving 13,631 shares. Filed Sep 18, 2026 (Form 4).
- Sold
- 240 shares
- Price
- US$17.90
- Value
- US$4,296
- Holding after
- 13,631 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- See Remarks
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 16, 2026 | Ordinary Shares | Sale | 240 | US$17.90 | 13,631 | Direct |
Source
Related
- Crescent Biopharma, Inc.
- Lynch Ryan
- Crescent Biopharma, Inc. shareholders
- Form 4 · Lynch Ryan · Jun 23, 2026
- Form 4 · Brumm Joshua T · Sep 18, 2026
- Form 4 · McNeill Jonathan · Sep 18, 2026
- Form 4 · Pinkas Jan · Sep 18, 2026
- Form 4 · Im Ellie Eunkyung · Sep 18, 2026
- Form 4 · Scalzo Richard William · Sep 18, 2026